2022 Annual Scientific Meeting
The pre-ASM nursing workshop is included with the Full ASM Delegate registration type. Space for this workshop is limited and you will need to indicate during the registration process if you would like to attend.
| Venue: Hyde Park Room, Sheraton Grand Hyde Park, Sydney | |||
|---|---|---|---|
|
0900-1700 |
ANZCHOG Nurses Pre Conference Workshop Program |
||
|
|
Chair: Chrissy Hanmore |
||
|
0900-0905 |
Welcome & housekeeping |
||
|
0905-0950
|
The importance of self-care and the impact of the pandemic Dr Justin Baker St Jude Children’s Research Hospital |
||
|
0950-1035
|
Hiding in plain sight. Nursing’s superpower
Prof Mei Krishnasamy Peter MacCallum Cancer Centre |
||
|
1035-1055 |
Morning tea |
||
|
1055-1120 |
Genomics and targeted therapy in childhood cancer Dr Loretta Lau |
||
|
1120-1145 |
Haemophilia overview and what’s the treatment plan for 2022 Grainne Dunne Sydney Children’s Hospital |
||
|
1145-1210 |
Fertility and emerging therapies Tejnei Vaishnav
Royal Hospital for Women, NSW |
||
|
1210-1230 |
The role and value of the research nurse A/Prof Natalie Bradford Queensland University of Technology |
||
|
1230-1300 |
Lunch |
||
|
1300-1430 |
What’s on your eLearning wishlist? eviQ Education showcase and workshop |
||
|
1430-1450 |
The Druggle, Improving Paediatric Oncology Drug Knowledge in Real Time Ms Genevieve Daly |
||
|
1450-1505 |
Afternoon tea |
||
|
1505-1535 |
Navigating end-of-life conversations with adolescents and young adults using the Australian Voicing My Choices tool: best practice & case examples Dr Ursula Samson-Daly, Cath O’Dwyer & Fiona Maguire Sydney Children’s Hospital |
||
|
1535-1605 |
Children and Adolescents with Cancer: Neuropsychological effects, education needs and interventions Dr Soheil Afshar Sydney Children’s Hospital |
||
|
1605-1635 |
Health and wellbeing after cancer: a multidisciplinary program for long-term survivors of childhood malignancies Dr Christina Signorelli, Karen Johnston & Rachael Bell Sydney Children’s Hospital Presented by Dr Jordana McLoone & Rachael Bell |
||
|
1635-1700 |
ANZCHOG Nurses Update, Evaluations and Close |
||
Brought to you by
You will have the option to register your attendance to the Parent Program during the registration process for the ASM.
If you would like to attend the virtual Parent Program only please proceed via the standard registration portal and use registration code*: PAR22 when prompted in order to bypass the ASM registration.
*Please note, by using this code, you will not be registered to attend the ASM or any of the social functions.
Example
|
0930-1510 AEST |
Parent Program |
||
|
|
Chair: Donna Drew |
||
|
0930-0935 |
Welcome and house keeping for virtual attendees |
||
|
0935-0955 |
Keeping up with school during and after childhood cancer
Joanna Fardell |
||
|
0955-1015 |
Managing social challenges during and after childhood cancer
Clarissa Schilstra |
||
|
1015-1030
|
Questions |
||
|
1030-1045 |
Morning tea |
||
|
1045-1115 |
When your child has cancer, goals of care, hope and compassion Justin Baker |
||
|
1115-1145 |
Minimising the psychological impact of cancer treatment on children and adolescents
Liane Willis |
||
|
1145-1215 |
Questions |
||
|
1215-1300 |
Lunch 1240-1300: Lunch session: "Would a national voice from parents lead to improved cancer support for families?" AND "What steps could be taken to build that voice?" A discussion led by Tim Rogers from Redkite |
||
|
|
Chair: Joanna Fardell |
||
|
1300-1320 |
Staying fit and active during and after cancer
Lauren Ha |
||
|
1320-1340 |
Managing the needs of siblings who have a brother or sister with cancer
Brittany McGill |
||
|
1350-1400 |
Afternoon tea |
||
|
1400-1420 |
When and how do I talk to my child about their cancer experience : side effects, experience, fertility
Tali Foreman |
||
|
1420-1440 |
Survivor’s Story: Clarissa will share her story about her cancer diagnosis, relapse, survivorship, academic achievements and being a mum
Clarissa |
||
|
1500-1510 |
Summary of the day & close |
||
The Parent Day program is scheduled in AEST.
Brought to you by
|
0900-0915 |
Opening ceremony |
||
|
0915-1015 |
Plenary 1 |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Improving patient outcomes through integrated paediatric palliative care Dr Justin Baker St Jude Children’s Research Hospital The ASM would like to acknowledge The Kids' Cancer Project for the support of Dr Justin Baker's attendance as an invited speaker.  |
||
|
1015-1045 |
Morning tea - Trade display and poster viewing
|
||
|
1045-1130 |
Plenary 2
|
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Old drugs and new: Still so much to learn about haemostasis in children |
||
|
1130-1215 |
Plenary 3 |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Fertility preservation in young people: The new standard of care Dr Yasmin Jayasinghe Royal Children’s Hospital Melbourne |
||
|
1215-1315 |
Lunch - Trade display and poster viewing |
||
|
1245-1315
|
Partner lunch symposium 1
Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT |
||
|
|
Location: Hyde Park Room |
||
|
|
Prof Selim Corbacioglu Brought to you by |
||
|
1315-1445 |
Concurrent 1: Non malignant haematology |
Concurrent 2: Translational Medicine |
Concurrent 3: Patient experience |
|
|
Location: Ballroom 1 |
Location: Ballroom 2 |
Location: Hyde Park Room |
|
|
Chair: Prof Paul Monagle Current management of sickle cell disease Dr Anthea Greenway Royal Children's Hospital Melbourne Iron deficiency anaemia Prof Sant-Rayn Parischa Walter and Eliza Hall Institute of Medical Research Transfusion medicine Dr Gemma Crighton Royal Children's Hospital Melbourne |
Chair: Dr Noemi Fuentes Bolanos
Computational Biology in Oncology Drug Discovery A/Prof Antoine de Weck Children's Cancer Institute A Comprehensive Patient-Derived Xenograft Model Platform to Support Translational Neuroblastoma Research Dr Jamie Fletcher Children's Cancer Institute A novel paediatric oncology mouse clinic Ms Zahra Abbas Telethon Kids Institute Targeting the Anti-apoptotic Protein BCL2 With Venetoclax Combination Treatment in High-risk Neuroblastoma Ms Madeleine Wheatley Children's Cancer Institute Exploiting Arginine Addiction to Treat High-Risk Neuroblastoma Dr Kimberley Hanssen Children's Cancer Institute |
Chair: Donna Drew Hoping against hope - Supporting hope in advancing illness Dr Justin Baker St Jude Children's Hospital Memphis The ASM would like to acknowledge The Kids' Cancer Project for the support of Dr Justin Baker's attendance as an invited speaker. ASSET: Collecting patient toxicity data and quality of life data together, where to next? Dr Joanna Fardell Kids Cancer Centre, Sydney Children's Hospital Do long term survivors adhere to recommendations provided by MDT review? Dr Jordana McLoone Kids Cancer Centre, Sydney Children's Hospital Developing a model of care for AYA patients with culturally diverse backgrounds Dr Azhani Amiruddin Crown Princess Mary Cancer Centre |
|
1445-1515 |
Afternoon tea - Trade display and poster viewing |
||
|
1515-1700 |
Concurrent 4: Non malignant haematology |
Concurrent 5: Solid tumours |
Concurrent 6: Patient experience |
|
|
Location: Ballroom 1 |
Location: Ballroom 2 |
Location: Hyde Park Room |
|
|
Chair: Prof Paul Monagle Novel treatments of ITP Current care in haemophilia National guidelines for ITP |
Chair: Dr Felicity Wright
Current therapies in neuroblastoma Dr Toby Trahair Kids Cancer Centre, Sydney Children's Hospital Recruitment principles and strategies for supportive care research in paediatric oncology A/ Prof Natalie Bradford Queensland University of Technology The outcome of paediatric extracranial malignant germ cell tumours: ten years experience of a single institution in Southern Vietnam Dr T. T. An Dao University of Medicine and Pharmacy At Ho Chi Minh City The NCI/COG Molecular Characterisation Project and Zero2 - an update Prof Nick Gottardo Perth Children's Hospital A/Prof Vanessa Tyrrell Children's Cancer Institute |
Chair: Chrissy Hanmore Health workers' understanding of and barriers to palliative care services for Aboriginal children with cancer “Torn in Two” Experiences of mothers who are pregnant when their child is diagnosed with cancer Identifying education and employment outcomes and support needs in Adolescents and Young Adults diagnosed with cancer Fathers’ Experiences of Childhood Cancer Home-Based Hydration for Chemotherapy – Its Clinical Impact and the Experience of Paediatric Oncology Patients and Their Families The management of pain for children hospitalised during Haematopoietic Stem Cell Transplantation |
|
1700-1900 |
Welcome reception |
||
|
0730-0830
|
Partner breakfast 1 CAR-T for ALL IN 2022 |
Partner breakfast 2 Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology |
|
|
|
Location: Ballroom 1 |
Location: Hyde Park Room |
|
|
|
SeongLin Khaw Brought to you by
|
Chair: Professor Nick Gottardo Dr Brendan McMullan Dr Daniel Yeoh Brought to you by
|
|
|
0900-1000 |
Plenary 4 |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Prof Claire Wakefield You should ask that: The different faces of life after treatment Dr Robert Battisti |
||
|
1000-1030 |
Morning tea - Trade display and poster viewing
|
||
|
1030-1130 |
ANZCHOG 2022 Best abstracts |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Molecular monitoring of ctDNA in neuroblastoma patients for response monitoring and relapse prediction Cardio-oncology guidelines for paediatric oncology patients: A Delphi consensus approach to inform risk stratification, surveillance and management during active cancer therapy. Generation and Multi-Dimensional Profiling of a Childhood Cancer Cell Line Atlas Defines New Therapeutic Opportunities |
||
|
1130-1200 |
ANZCHOG foundations lecture |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Prof Les White A history of paediatric stem cell transplantation in Australia Prof Marcus Vowels |
||
|
1200-1300 |
Lunch - Trade display and poster viewing |
||
|
1225-1255 |
Partner lunch symposium 2 Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer |
||
|
|
Location: Hyde Park Room |
||
|
|
Professor David Ziegler MD Theodore W. Laetsch Brought to you by
|
||
|
1300-1430 |
Concurrent 7: Neuro-oncology |
Concurrent 8: Precision medicine |
Concurrent 9: Global oncology in Oceania: A joint SIOP-ANZCHOG symposium across disciplines |
|
|
Location: Ballroom 2 |
Location: Ballroom 1 |
Location: Hyde Park Room |
|
|
Chair: Dr Neevika Manoharan Holistic care for paediatric brain tumours: 2022 and beyond
Epigenetic regulation of innate signaling in brain tumours: Implications for novel therapeutic approaches. Preliminary Analysis of the Pharmaco-phospho-proteo-genomic Landscape of Paediatric High-grade Gliomas Determining the Clinical Utility of the Immune Modulating Antibody Anti-CD47 in a Preclinical Model of Medulloblastoma. The development of ACT001 as a novel combination therapeutic for diffuse intrinsic pontine gliomas |
Chair: Dr Karen McCleary Precision Medicine 101 High-Throughput Drug Testing on Patient-Derived Models Identifies Novel Rational Treatment Options for Paediatric Cancer Patients Precision medicine is changing the roles of healthcare professionals, scientists, and research staff: Learnings from a childhood cancer precision medicine trial. |
Chairs: Professor Claire Wakefield & Dr Michael Sullivan Improving child cancer care in Oceania, working with the World Health Organisation, and welcome remarks from global leaders Supporting nursing education in Oceania: What’s going on in our neighbourhood? A showcase of child cancer care strengths and challenges in our region, featuring clinicians from Papua New Guinea, Fiji, New Caledonia, Tonga and Timor Leste Discussion and Q&A |
|
1430-1500 |
Afternoon tea - Trade display and poster viewing |
||
|
1500-1630 |
Concurrent 10: Neuro-oncology |
Concurrent 11: Leukaemia/Cellular Therapy |
Concurrent 12: ANZCHOG Trial & Research updates |
|
|
Location: Ballroom 2 |
Location: Ballroom 1 |
Location: Hyde Park Room |
|
|
Chair: Prof Richard Cohn
Long-term control and safety of larotrectinib in a cohort of adult and paediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumours A/ Prof Jordan Hansford Women's and Children's Hospital Adelaide Australasian Methylation Array Profiling – an Update on the AIM BRAIN PROject Dr Christine White Victorian Clinical Genetics Services Characteristics of Children with Brain Cancer: A 10-Year Retrospective Cohort A/ Prof Natalie Bradford Queensland University of Technology Preclinical optimisation of the PI3K/AKT/mTOR inhibitor paxalisib for the treatment of diffuse intrinsic pontine glioma Dr Ryan Duchatel University Of Newcastle |
Chair: Dr Adam Nelson CAR-T cells for B-ALL: Real world data and beyond Cooperative deletions of key lymphoid transcription factors strongly associated with recurrent genomic lesions in B-cell acute lymphoblastic leukaemia Vincristine-Induced Peripheral Neuropathy: Assessing Preventable Strategies in Paediatric Acute Lymphoblastic Leukemia. Reinventing The Wheel - Changing High Dose Methotrexate Habits Chimeric Antigen Receptor (CAR) T cell Therapy: Updated Outcomes at a Single Centre |
Chair: Dr Maria Kirby 1500-1515: Registries, biobanking and supportive care research 1515-1545: Leukaemia/lymphoma and solid tumours clinical trials 1545-1625: CNS clinical trials and ZERO2 initiatives 1625-1630: Trial governance updates |
|
1630-1700 |
Meet the experts 1 Clinical use of asparaginase |
Meet the expert 2 |
|
|
|
Location: Ballroom 1 |
Location: Ballroom 2 |
|
|
|
Dr Siobhan Cross Jessica Nicholson Brought to you by
|
Dr Martin Campbell Dr Aleksandra Wieczorek Brought to you by
|
|
|
1900-2300 |
Gala dinner The Eveleigh, Bay 3, 2 Locomotive St, Eveleigh NSW 2015 |
||
The ASM would like to acknowledge the Robert Connor Dawes Foundation for the support of A/Prof Jordan Hansford's attendance as an invited speaker.
|
0900-1100 |
Panel discussion |
||
|
|
Location: Grand Ballroom |
||
|
|
Moderator: Annabel Crabb ABC journalist Ava’s Journey – Decision making in the age of early phase trials Panelists: Prof David Ziegler, Kids Cancer Centre, Sydney Children's Hospital; Dr Justin Baker, St. Jude Children’s Research Hospital; Prof Mary Chiarella, University of Sydney; Ben Charlton Maryanne Larkin |
||
|
1100-1130 |
Morning tea - Trade display and poster viewing
|
||
|
1130-1230 |
Plenary 5
|
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Communication as a Cornerstone of Care: What We Say and How We Say It Matters
|
||
|
1230-1300 |
Closing ceremony |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Best abstract awards Thanks for attending ASM 2022 Join us for ASM 2023 |
||
| Day 1 - Thursday 28 July | |||
|---|---|---|---|
|
1245 - 1315 |
Partner Lunch Symposium Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT |
||
|
|
Prof Selim Corbacioglu Children's Hospital Regensburg Germany Brought to you by  |
||
| Day 2 - Friday 29 July | ||
|---|---|---|
|
0730 - 0830 |
Partner breakfast 1 CAR-T for ALL IN 2022 |
Partner breakfast 2 Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology |
|
|
SeongLin Khaw Brought to you by
|
Chair: Professor Nick Gottardo Dr Brendan McMullan Dr Daniel Yeoh Brought to you by
|
|
1225 - 1255 |
Partner Lunch Symposium 2 Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer |
|
|
|
Professor David Ziegler MD Theodore W. Laetsch Brought to you by
|
|
|
1630 - 1700 |
Meet the experts 1 Clinical use of asparaginase |
Meet the experts 2 Dinutuximab beta as immunotherapy in high-risk neuroblastoma |
|
|
Dr Siobhan Cross Jessica Nicholson Brought to you by
|
Dr Martin Campbell Dr Aleksandra Wieczorek Brought to you by
|
| Day 2 - Friday 29 July | ||
|---|---|---|
|
0730 - 0830 |
||
|
|
Brought to you by
|
Professor Nick Gottardo Dr Brendan McMullan Dr Daniel Yeoh Brought to you by
|
|
1230 - 1300 |
Partner Lunch Symposium 2 Efficacy and safety of larotrectinib in pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer |
|
|
|
Professor David Ziegler Kids Cancer Centre MD Theodore W. Laetsch Children’s Hospital of Philadelphia/University of Pennsylvania Brought to you by  |
|
|
1630 - 1700 |
Meet the experts 1 Clinical use of asparaginase |
Meet the experts 2 Dinutuximab beta as immunotherapy in high-risk neuroblastoma |
|
|
Dr Siobhan Cross Jessica Nicholson Brought to you by
|
Dr Martin Campbell Royal Children’s Hospital Melbourne Dr Aleksandra Wieczorek University Children’s Hospital, Krakow Brought to you by 
|
Other Invited Speakers
Dr Tina Carter
Perth Children’s Hospital
Janine Furmedge
Royal Children’s Hospital Melbourne
Dr Anthea Greenway
Royal Children’s Hospital Melbourne
Dr Jordana McLoone
Kids Cancer Centre, Sydney Children’s Hospital
Prof Sant-Rayn Parischa
Walter and Eliza Hall Institute of Medical Research
